An Indian drugmaker has partnered with Russia's Sputnik V coronavirus vaccine developer on Friday to produce 200 million doses of the Russian coronavirus vaccine.

Indian drugmaker enters into partnership to produce 200 million doses of Sputnik V vaccine

strides-pharma-science

Strides Pharma Science, News on Strides Pharma Science, stories on Strides Pharma Science, articles on Strides Pharma Science, Strides Pharma Science stories at Wion, Strides Pharma Science news, Strides Pharma Science latest news

strides pharma-science

Indian drugmaker enters into partnership to produce 200 million doses of Sputnik V vaccine